首页 > 最新文献

Kidney International Reports最新文献

英文 中文
Persistent ANCA Positivity in Granulicatella adiacens-associated Endocarditis: Diagnostic Implications of Methodological Variability 持续性ANCA阳性在棘粒霉相关的心内膜炎:方法变异的诊断意义
IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-15 DOI: 10.1016/j.ekir.2025.103734
Vincent Linse , Kirsten De Groot , Thorsten Wiech , Ulrich J. Sachs , Bernhard Hellmich , Faeq Husain-Syed
{"title":"Persistent ANCA Positivity in Granulicatella adiacens-associated Endocarditis: Diagnostic Implications of Methodological Variability","authors":"Vincent Linse , Kirsten De Groot , Thorsten Wiech , Ulrich J. Sachs , Bernhard Hellmich , Faeq Husain-Syed","doi":"10.1016/j.ekir.2025.103734","DOIUrl":"10.1016/j.ekir.2025.103734","url":null,"abstract":"","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"11 2","pages":"Article 103734"},"PeriodicalIF":5.7,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145881195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remote Monitoring of Dialysis: A Successful Model for Low- and Middle-Income Countries 透析远程监测:低收入和中等收入国家的成功模式
IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-15 DOI: 10.1016/j.ekir.2025.103725
Manjusha Yadla , Priyadarshini John
{"title":"Remote Monitoring of Dialysis: A Successful Model for Low- and Middle-Income Countries","authors":"Manjusha Yadla , Priyadarshini John","doi":"10.1016/j.ekir.2025.103725","DOIUrl":"10.1016/j.ekir.2025.103725","url":null,"abstract":"","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"11 3","pages":"Article 103725"},"PeriodicalIF":5.7,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145915211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparison of Pregnancy Outcomes in Women Receiving Intensive Hemodialysis Versus Kidney Transplant Recipients 接受强化血液透析的妇女与接受肾移植的妇女妊娠结局的比较
IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-15 DOI: 10.1016/j.ekir.2025.103722
Arrti A. Bhasin , Rohan D’Souza , Dini Hui , Nir Melamed , Christopher T. Chan , Michelle A. Hladunewich

Introduction

Tailored hemodialysis prescriptions, including more frequent and intensive regimens, may improve pregnancy outcomes, yet most women are counselled to delay conception until after a successful kidney transplantation.

Methods

We conducted a retrospective cohort study between 2000 and 2023 in Toronto, Ontario, Canada to compare pregnancy outcomes of women receiving intensified hemodialysis versus kidney transplant recipients.

Results

We included 48 pregnancies in 37 women receiving hemodialysis and 96 pregnancies in 60 women conceiving post–kidney transplantation. The 2 patient populations managed by the same multidisciplinary team had similar live birth rates (80% in hemodialysis and 76% in transplant patients; P = 0.68). However, the hemodialysis cohort had a shorter pregnancy duration (36.2 weeks; interquartile range [IQR]: 32.5–37.1 vs. 37.0 weeks; IQR; 35.7–38.0; P = 0.004) and smaller infants at birth (2202 g; IQR: 1600-2750 vs. 2766 g; IQR: 2380–3180; P < 0.001). No difference was observed in the proportion of pregnancies with reported pregnancy-associated complications (67% in hemodialysis and 73% in transplant; P = 0.53), including hypertensive disorders of pregnancy at 33% in the hemodialysis cohort and 47% among transplant recipients (P = 0.18).

Conclusion

With appropriate counselling and management, pregnancy while on hemodialysis may be considered a viable alternative to conceiving post–renal transplant for women without imminent access to a donor.
量身定制的血液透析处方,包括更频繁和强化的治疗方案,可能会改善妊娠结局,但大多数妇女被建议推迟怀孕,直到肾移植成功后。方法:我们于2000年至2023年在加拿大安大略省多伦多进行了一项回顾性队列研究,比较接受强化血液透析的妇女与接受肾移植的妇女的妊娠结局。结果我们纳入了37例接受血液透析的48例妊娠和60例肾移植后妊娠的96例妊娠。同一多学科小组管理的两组患者的活产率相似(血液透析患者为80%,移植患者为76%;P = 0.68)。然而,血液透析组妊娠期较短(36.2周;四分位数间距[IQR]: 32.5-37.1 vs. 37.0周;IQR; 35.7-38.0; P = 0.004),出生时婴儿较小(2202 g; IQR: 1600-2750 vs. 2766 g; IQR: 2380-3180; P < 0.001)。报告妊娠相关并发症的妊娠比例(血液透析组为67%,移植组为73%,P = 0.53)无差异,包括妊娠高血压疾病在血液透析组为33%,移植组为47% (P = 0.18)。结论通过适当的咨询和管理,对于无法立即获得供体的妇女,在血液透析期间怀孕可能被认为是肾移植后怀孕的可行选择。
{"title":"A Comparison of Pregnancy Outcomes in Women Receiving Intensive Hemodialysis Versus Kidney Transplant Recipients","authors":"Arrti A. Bhasin ,&nbsp;Rohan D’Souza ,&nbsp;Dini Hui ,&nbsp;Nir Melamed ,&nbsp;Christopher T. Chan ,&nbsp;Michelle A. Hladunewich","doi":"10.1016/j.ekir.2025.103722","DOIUrl":"10.1016/j.ekir.2025.103722","url":null,"abstract":"<div><h3>Introduction</h3><div>Tailored hemodialysis prescriptions, including more frequent and intensive regimens, may improve pregnancy outcomes, yet most women are counselled to delay conception until after a successful kidney transplantation.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study between 2000 and 2023 in Toronto, Ontario, Canada to compare pregnancy outcomes of women receiving intensified hemodialysis versus kidney transplant recipients.</div></div><div><h3>Results</h3><div>We included 48 pregnancies in 37 women receiving hemodialysis and 96 pregnancies in 60 women conceiving post–kidney transplantation. The 2 patient populations managed by the same multidisciplinary team had similar live birth rates (80% in hemodialysis and 76% in transplant patients; <em>P</em> = 0.68). However, the hemodialysis cohort had a shorter pregnancy duration (36.2 weeks; interquartile range [IQR]: 32.5–37.1 vs. 37.0 weeks; IQR; 35.7–38.0; <em>P</em> = 0.004) and smaller infants at birth (2202 g; IQR: 1600-2750 vs. 2766 g; IQR: 2380–3180; <em>P</em> &lt; 0.001). No difference was observed in the proportion of pregnancies with reported pregnancy-associated complications (67% in hemodialysis and 73% in transplant; <em>P</em> = 0.53), including hypertensive disorders of pregnancy at 33% in the hemodialysis cohort and 47% among transplant recipients (<em>P</em> = 0.18).</div></div><div><h3>Conclusion</h3><div>With appropriate counselling and management, pregnancy while on hemodialysis may be considered a viable alternative to conceiving post–renal transplant for women without imminent access to a donor.</div></div>","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"11 3","pages":"Article 103722"},"PeriodicalIF":5.7,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146078956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pseudo–Acute Kidney Injury With Tyrosine Kinase Inhibitors: Utility of the Creatinine–to–Cystatin C Ratio 假性急性肾损伤与酪氨酸激酶抑制剂:肌酐与胱抑素C比值的效用
IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-15 DOI: 10.1016/j.ekir.2025.103733
Natacha Rodrigues , Chintan V. Shah
{"title":"Pseudo–Acute Kidney Injury With Tyrosine Kinase Inhibitors: Utility of the Creatinine–to–Cystatin C Ratio","authors":"Natacha Rodrigues ,&nbsp;Chintan V. Shah","doi":"10.1016/j.ekir.2025.103733","DOIUrl":"10.1016/j.ekir.2025.103733","url":null,"abstract":"","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"11 3","pages":"Article 103733"},"PeriodicalIF":5.7,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145920951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic Prediction of Kidney Function: Why Measured GFR Matters 肾脏功能的遗传预测:为什么测量GFR很重要
IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-13 DOI: 10.1016/j.ekir.2025.103724
Atlas Khan
{"title":"Genetic Prediction of Kidney Function: Why Measured GFR Matters","authors":"Atlas Khan","doi":"10.1016/j.ekir.2025.103724","DOIUrl":"10.1016/j.ekir.2025.103724","url":null,"abstract":"","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"11 2","pages":"Article 103724"},"PeriodicalIF":5.7,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145978179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complement Alternative Pathway Dominance in Atypical Hemolytic Uremic Syndrome Revealed by Endothelial Bioassays 内皮生物检测揭示非典型溶血性尿毒症综合征补体替代途径优势
IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-12 DOI: 10.1016/j.ekir.2025.103717
Donata Santarsiero , Sara Gastoldi , Valeria Guaschino , Elena Bresin , Ilaria Pagani , Andrea Pasini , Elena Romano , Ariela Benigni , Giuseppe Remuzzi , Marina Noris , Sistiana Aiello
{"title":"Complement Alternative Pathway Dominance in Atypical Hemolytic Uremic Syndrome Revealed by Endothelial Bioassays","authors":"Donata Santarsiero ,&nbsp;Sara Gastoldi ,&nbsp;Valeria Guaschino ,&nbsp;Elena Bresin ,&nbsp;Ilaria Pagani ,&nbsp;Andrea Pasini ,&nbsp;Elena Romano ,&nbsp;Ariela Benigni ,&nbsp;Giuseppe Remuzzi ,&nbsp;Marina Noris ,&nbsp;Sistiana Aiello","doi":"10.1016/j.ekir.2025.103717","DOIUrl":"10.1016/j.ekir.2025.103717","url":null,"abstract":"","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"11 3","pages":"Article 103717"},"PeriodicalIF":5.7,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145929208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intradialytic Hypotensive Episodes are Only Occasionally Associated With Adverse Symptoms 溶栓性低血压发作仅偶尔伴有不良症状。
IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-12 DOI: 10.1016/j.ekir.2025.103718
Sabrine Chaara , Paul A. Rootjes , Miquéla I.Y. Bergtop , Muriel P.C. Grooteman , Peiyun Liu , Menso J. Nubé , Gertrude Wijngaarden , Camiel L.M. de Roij van Zuijdewijn

Introduction

Although intradialytic hypotension (IDH) is a frequent complication of hemodialysis (HD), a consensus definition is lacking. Adverse symptoms and/or interventions are a prerequisite in guidelines; however, a threshold-based blood pressure (BP) definition appeared most strongly associated with mortality. In this study, we evaluated the association of IDH with both real-time symptoms and physical intradialytic patient-reported outcome measures (PID-PROMs) in prevalent HD and hemodiafiltration (HDF) patients.

Methods

This is a secondary analysis of the HOLLANT study, a randomized cross-over trial comparing 4 dialysis modalities (i.e., standard HD, cool high-flux HD, low-volume HDF, and high-volume HDF), each applied for 2 weeks in 40 patients. In each second treatment week, BP was measured every 15 minutes and when symptoms occurred. Symptoms were documented real-time and PID-PROMs were collected after each modality. Considering that symptoms occurred independent of dialysis mode, data from all treatment modalities were pooled. IDH was threshold-defined (systolic BP [SBP] < 90 or < 100 mm Hg, dependent on predialysis SBP). The incidence of symptomatic IDH (sIDH) and asymptomatic IDH (aIDH) was assessed, with sIDH defined by concurrent symptoms. When real-time symptoms arose, attribution to IDH was appraised according to the threshold, National Kidney Disease Outcomes Quality Initiative, and the European Best Practice Guideline definitions. Differences in PID-PROMs were analyzed in tertiles of IDH occurrence.

Results

In 20.1% of 458 treatments, 222 IDH episodes were observed (0.48/session). The majority occurred toward the end of dialysis and 98% was asymptomatic. Real-time reported symptoms (n = 24) were noted in 5.2% of the sessions. Although half were BP-related (n = 13/24), just 4 fulfilled the threshold criteria. Associations between IDH and PID-PROMs were largely absent.

Conclusion

aIDH exceeds sIDH by far. Therefore, symptom-based definitions severely underestimate aIDH incidence. Both real-time occurring symptoms and PID-PROMs are only occasionally associated with IDH.
导语:虽然透析性低血压(IDH)是血液透析(HD)的常见并发症,但缺乏共识的定义。不良症状和/或干预措施是指南的先决条件;然而,以阈值为基础的血压(BP)定义与死亡率的关系最为密切。在这项研究中,我们评估了IDH与流行HD和血液滤过(HDF)患者的实时症状和生理分析患者报告的结果测量(PID-PROMs)的关系。方法:这是HOLLANT研究的二次分析,这是一项随机交叉试验,比较了4种透析方式(即标准HD、冷高通量HD、低容量HDF和高容量HDF),每种透析方式在40例患者中应用2周。在第二个治疗周,每15分钟及出现症状时测量一次血压。实时记录症状,并在每种模式后收集pid - prom。考虑到症状的发生与透析方式无关,我们汇总了所有治疗方式的数据。IDH是阈值定义的(收缩压[SBP] < 90或< 100 mm Hg,取决于透析前收缩压)。评估有症状性IDH (sIDH)和无症状性IDH (aIDH)的发生率,以并发症状定义sIDH。当实时症状出现时,根据阈值、国家肾脏疾病结局质量倡议和欧洲最佳实践指南定义评估IDH的归因。分析IDH发生分位数中pid - prom的差异。结果:在458例治疗中,20.1%的患者出现222例IDH发作(0.48例/次)。大多数发生在透析结束时,98%无症状。实时报告的症状(n = 24)在5.2%的疗程中被记录。虽然一半与bp相关(n = 13/24),但只有4例符合阈值标准。IDH和pid - prom之间的关联基本不存在。结论:aIDH远远超过sIDH。因此,基于症状的定义严重低估了aIDH的发病率。实时发生的症状和pid - prom仅偶尔与IDH相关。
{"title":"Intradialytic Hypotensive Episodes are Only Occasionally Associated With Adverse Symptoms","authors":"Sabrine Chaara ,&nbsp;Paul A. Rootjes ,&nbsp;Miquéla I.Y. Bergtop ,&nbsp;Muriel P.C. Grooteman ,&nbsp;Peiyun Liu ,&nbsp;Menso J. Nubé ,&nbsp;Gertrude Wijngaarden ,&nbsp;Camiel L.M. de Roij van Zuijdewijn","doi":"10.1016/j.ekir.2025.103718","DOIUrl":"10.1016/j.ekir.2025.103718","url":null,"abstract":"<div><h3>Introduction</h3><div>Although intradialytic hypotension (IDH) is a frequent complication of hemodialysis (HD), a consensus definition is lacking. Adverse symptoms and/or interventions are a prerequisite in guidelines; however, a threshold-based blood pressure (BP) definition appeared most strongly associated with mortality. In this study, we evaluated the association of IDH with both real-time symptoms and physical intradialytic patient-reported outcome measures (PID-PROMs) in prevalent HD and hemodiafiltration (HDF) patients.</div></div><div><h3>Methods</h3><div>This is a secondary analysis of the HOLLANT study, a randomized cross-over trial comparing 4 dialysis modalities (i.e., standard HD, cool high-flux HD, low-volume HDF, and high-volume HDF), each applied for 2 weeks in 40 patients. In each second treatment week, BP was measured every 15 minutes and when symptoms occurred. Symptoms were documented real-time and PID-PROMs were collected after each modality. Considering that symptoms occurred independent of dialysis mode, data from all treatment modalities were pooled. IDH was threshold-defined (systolic BP [SBP] &lt; 90 or &lt; 100 mm Hg, dependent on predialysis SBP). The incidence of symptomatic IDH (sIDH) and asymptomatic IDH (aIDH) was assessed, with sIDH defined by concurrent symptoms. When real-time symptoms arose, attribution to IDH was appraised according to the threshold, National Kidney Disease Outcomes Quality Initiative, and the European Best Practice Guideline definitions. Differences in PID-PROMs were analyzed in tertiles of IDH occurrence.</div></div><div><h3>Results</h3><div>In 20.1% of 458 treatments, 222 IDH episodes were observed (0.48/session). The majority occurred toward the end of dialysis and 98% was asymptomatic. Real-time reported symptoms (<em>n</em> = 24) were noted in 5.2% of the sessions. Although half were BP-related (<em>n</em> = 13/24), just 4 fulfilled the threshold criteria. Associations between IDH and PID-PROMs were largely absent.</div></div><div><h3>Conclusion</h3><div>aIDH exceeds sIDH by far. Therefore, symptom-based definitions severely underestimate aIDH incidence. Both real-time occurring symptoms and PID-PROMs are only occasionally associated with IDH.</div></div>","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"11 3","pages":"Article 103718"},"PeriodicalIF":5.7,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146180891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tailored Kidney Stone Prevention Improves Metabolic Risk Factors and Reduces Renal Colic Rate 量身定制的肾结石预防改善代谢危险因素,降低肾绞痛率
IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-12 DOI: 10.1016/j.ekir.2025.103719
Els Van de Perre , Florine V. Janssens , Dieter De Clerck , Wilfried Cools , Peter Janssens , Mandelina Allamani , Tom Robberechts , Freya Van Hulle , Lissa Pipeleers , Karlien François , Dominique Bazin , Christian Tielemans , Michel Daudon , Emmanuel Letavernier , Karl M. Wissing

Introduction

There is limited real-world data on the effectiveness of combined prophylactic measures to prevent recurrent kidney stone formation.

Methods

This single-center retrospective study evaluated the effect of combined, patient-tailored prophylaxis on metabolic risk factors, urinary crystallization risk indices, and renal colic and urological intervention rates in a real-life clinical setting.

Results

Four hundred ninety patients with nephrolithiasis (NL) with a median follow-up of 12.8 months were evaluated. After the introduction of prophylaxis, the main metabolic risk factors, namely urinary volume, oxalate, calcium, and citrate excretion improved significantly in patients presenting the specific risk factor at baseline (+ 653 ml/24 h for urinary volume, − 10.9 mg/24 h for oxaluria, − 2.35 mmol/24 h for calciuria, and + 901 μmol/24 h for citraturia; all P < 0.001). Relative urinary calcium oxalate supersaturation and Tiselius risk index improved significantly in the total population (− 1.68 and − 0.33, respectively; both P < 0.001). Renal colic and urological intervention rates improved significantly (from 0.82 to 0.21 /1000 d at risk, P < 0.001 for renal colic rate; and from 0.31 to 0.21 /1000 d at risk, P < 0.001 for urological intervention rate). A score expressing overall control of the 4 main metabolic risk factors was significantly associated with a reduction of renal colic rate during follow-up.

Conclusion

Combined, patient-tailored prophylaxis in kidney stone formers significantly improves metabolic risk factors and urinary crystallization risk indices, resulting in a significant reduction of renal colic and urological intervention rates.
关于联合预防措施预防肾结石复发的有效性的实际数据有限。方法本研究是一项单中心回顾性研究,评估了在现实临床环境中,针对患者的联合预防对代谢危险因素、尿结晶危险指标、肾绞痛和泌尿外科干预率的影响。结果490例肾结石患者,中位随访时间为12.8个月。在引入预防措施后,基线时具有特定危险因素的患者的主要代谢危险因素,即尿量、草酸盐、钙和柠檬酸盐排泄显著改善(尿量+ 653 ml/24 h,草酸尿- 10.9 mg/24 h,钙尿- 2.35 mmol/24 h,柠檬酸尿+ 901 μmol/24 h, P均为0.001)。相对尿草酸钙过饱和度和Tiselius风险指数在总人口中显著改善(分别为- 1.68和- 0.33,P均为0.001)。肾绞痛和泌尿系统干预率显著提高(从0.82 /1000 d降至0.21 /1000 d,风险组P <; 0.001;从0.31 /1000 d降至0.21 /1000 d,风险组P <; 0.001)。在随访期间,表达4个主要代谢危险因素的总体控制的评分与肾绞痛发生率的降低显著相关。结论综合用药可显著改善肾结石患者的代谢危险因素和尿结晶危险指标,显著降低肾绞痛发生率和泌尿外科干预率。
{"title":"Tailored Kidney Stone Prevention Improves Metabolic Risk Factors and Reduces Renal Colic Rate","authors":"Els Van de Perre ,&nbsp;Florine V. Janssens ,&nbsp;Dieter De Clerck ,&nbsp;Wilfried Cools ,&nbsp;Peter Janssens ,&nbsp;Mandelina Allamani ,&nbsp;Tom Robberechts ,&nbsp;Freya Van Hulle ,&nbsp;Lissa Pipeleers ,&nbsp;Karlien François ,&nbsp;Dominique Bazin ,&nbsp;Christian Tielemans ,&nbsp;Michel Daudon ,&nbsp;Emmanuel Letavernier ,&nbsp;Karl M. Wissing","doi":"10.1016/j.ekir.2025.103719","DOIUrl":"10.1016/j.ekir.2025.103719","url":null,"abstract":"<div><h3>Introduction</h3><div>There is limited real-world data on the effectiveness of combined prophylactic measures to prevent recurrent kidney stone formation.</div></div><div><h3>Methods</h3><div>This single-center retrospective study evaluated the effect of combined, patient-tailored prophylaxis on metabolic risk factors, urinary crystallization risk indices, and renal colic and urological intervention rates in a real-life clinical setting.</div></div><div><h3>Results</h3><div>Four hundred ninety patients with nephrolithiasis (NL) with a median follow-up of 12.8 months were evaluated. After the introduction of prophylaxis, the main metabolic risk factors, namely urinary volume, oxalate, calcium, and citrate excretion improved significantly in patients presenting the specific risk factor at baseline (+ 653 ml/24 h for urinary volume, − 10.9 mg/24 h for oxaluria, − 2.35 mmol/24 h for calciuria, and + 901 μmol/24 h for citraturia; all <em>P</em> &lt; 0.001). Relative urinary calcium oxalate supersaturation and Tiselius risk index improved significantly in the total population (− 1.68 and − 0.33, respectively; both <em>P</em> &lt; 0.001). Renal colic and urological intervention rates improved significantly (from 0.82 to 0.21 /1000 d at risk, <em>P</em> &lt; 0.001 for renal colic rate; and from 0.31 to 0.21 /1000 d at risk, <em>P</em> &lt; 0.001 for urological intervention rate). A score expressing overall control of the 4 main metabolic risk factors was significantly associated with a reduction of renal colic rate during follow-up.</div></div><div><h3>Conclusion</h3><div>Combined, patient-tailored prophylaxis in kidney stone formers significantly improves metabolic risk factors and urinary crystallization risk indices, resulting in a significant reduction of renal colic and urological intervention rates.</div></div>","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"11 3","pages":"Article 103719"},"PeriodicalIF":5.7,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145980202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regional Variation in Early Kidney Transplant Access Across Dialysis Facilities in 4 US Regions 美国4个地区透析设施早期肾移植可及性的区域差异
IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-12 DOI: 10.1016/j.ekir.2025.103721
Jade Buford , Mengyu Di , Jessica L. Harding , Kelsey Drewry , Catherine Kelty , Adam Wilk , Anne Huml , Ana P. Rossi , Sumit Mohan , Bruce E. Gelb , Bhavna Chopra , Daniel Glicklich , Prince Mohan Anand , Matthew Handmacher , Laura Mulloy , Wasim A. Dar , Amber Reeves-Daniel , Enver Akalin , Kenneth J. McPartland , Stephen O. Pastan , Rachel E. Patzer

Introduction

Pretransplant access varies, but whether pretransplant steps vary regionally across dialysis facilities remains unclear.

Methods

We identified 62,467 adults (aged 18–80 years) referred from 2471 dialysis facilities and 27,171 initiating transplant evaluation from 2188 facilities in New England, New York, Southeast, and Ohio River Valley within the Early Steps to Transplant Access Registry (E-STAR) (January 1, 2015–December 31, 2023), linked with US Renal Data System (USRDS) and the Scientific Registry of Transplant Recipients data, followed-up through March 2, 2024. We examined dialysis facility–level proportions of evaluation start within 6 months of referral and waitlisting within 1 year of evaluation start. Descriptive statistics using analysis of variance and chi-square tests summarized outcome distributions and baseline characteristics within tertiles of outcome proportions, overall and by region.

Results

Evaluation start within 6 months across 2471 facilities varied from 0% to 100%; median within-facility proportion was 50% (interquartile range: 33.3%–64.3%), ranging from 33.3% (18.2%–50%) in the Ohio River Valley to 66.7% (50%–76.7%) in New York. Waitlisting within 1 year of evaluation start varied from 0% to 100% across 2188 facilities; median within-facility proportion was 41.2% (26.0%–60%), lowest in the Southeast (31.9% [20%–43.8%]) and similar across other regions (50%). Facilities in the lowest tertile of evaluation start proportions (< 39.13%) more often treated patients from high-poverty neighborhoods (36.8% vs. 29.2%) and were for-profit (82.4% vs. 73.5%) than the highest tertile (> 58.33%). These characteristics varied by region. Facility-level clustering explained 12.2% (95% confidence interval [CI]: 10.5%–13.5%) of variation in evaluation and 8.2% (6.7%–9.2%) in waitlisting.

Conclusion

Substantial regional variation in pretransplant access across dialysis facilities reinforces the need for region-specific strategies to improve access.
移植前的获取途径各不相同,但移植前的步骤是否因透析设施而异仍不清楚。方法:在移植准入早期步骤注册(E-STAR)(2015年1月1日- 2023年12月31日)中,我们从2471家透析机构中筛选了62467名成年人(18-80岁),从新英格兰、纽约、东南部和俄亥俄河谷的2188家机构中筛选了27171名开始移植评估的成年人,并与美国肾脏数据系统(USRDS)和移植接受者科学登记处数据相关联,随访至2024年3月2日。我们检查了透析设施级别的评估开始6个月内转诊和评估开始1年内等待名单的比例。使用方差分析和卡方检验的描述性统计总结了总体和区域内结果比例的分位数内的结果分布和基线特征。结果2471家机构在6个月内开始评估,从0%到100%不等;设施内比例中位数为50%(四分位数范围:33.3% - 64.3%),从俄亥俄河谷的33.3%(18.2%-50%)到纽约的66.7%(50% - 76.7%)。在2188个设施中,1年内评估开始的等待名单从0%到100%不等;设施内比例中位数为41.2%(26.0%-60%),东南地区最低(31.9%[20%-43.8%]),其他地区相似(50%)。评估开始比例最低的五分位数(39.13%)的医院比最高的五分位数(58.33%)更多地治疗来自高贫困社区的患者(36.8%对29.2%)和营利性医院(82.4%对73.5%)。这些特征因地区而异。设施级别的聚类解释了12.2%(95%可信区间[CI]: 10.5%-13.5%)的评估差异和8.2%(6.7%-9.2%)的等待列表差异。结论:透析设施移植前可及性的区域差异加强了制定区域特定策略以改善可及性的必要性。
{"title":"Regional Variation in Early Kidney Transplant Access Across Dialysis Facilities in 4 US Regions","authors":"Jade Buford ,&nbsp;Mengyu Di ,&nbsp;Jessica L. Harding ,&nbsp;Kelsey Drewry ,&nbsp;Catherine Kelty ,&nbsp;Adam Wilk ,&nbsp;Anne Huml ,&nbsp;Ana P. Rossi ,&nbsp;Sumit Mohan ,&nbsp;Bruce E. Gelb ,&nbsp;Bhavna Chopra ,&nbsp;Daniel Glicklich ,&nbsp;Prince Mohan Anand ,&nbsp;Matthew Handmacher ,&nbsp;Laura Mulloy ,&nbsp;Wasim A. Dar ,&nbsp;Amber Reeves-Daniel ,&nbsp;Enver Akalin ,&nbsp;Kenneth J. McPartland ,&nbsp;Stephen O. Pastan ,&nbsp;Rachel E. Patzer","doi":"10.1016/j.ekir.2025.103721","DOIUrl":"10.1016/j.ekir.2025.103721","url":null,"abstract":"<div><h3>Introduction</h3><div>Pretransplant access varies, but whether pretransplant steps vary regionally across dialysis facilities remains unclear.</div></div><div><h3>Methods</h3><div>We identified 62,467 adults (aged 18–80 years) referred from 2471 dialysis facilities and 27,171 initiating transplant evaluation from 2188 facilities in New England, New York, Southeast, and Ohio River Valley within the Early Steps to Transplant Access Registry (E-STAR) (January 1, 2015–December 31, 2023), linked with US Renal Data System (USRDS) and the Scientific Registry of Transplant Recipients data, followed-up through March 2, 2024. We examined dialysis facility–level proportions of evaluation start within 6 months of referral and waitlisting within 1 year of evaluation start. Descriptive statistics using analysis of variance and chi-square tests summarized outcome distributions and baseline characteristics within tertiles of outcome proportions, overall and by region.</div></div><div><h3>Results</h3><div>Evaluation start within 6 months across 2471 facilities varied from 0% to 100%; median within-facility proportion was 50% (interquartile range: 33.3%–64.3%), ranging from 33.3% (18.2%–50%) in the Ohio River Valley to 66.7% (50%–76.7%) in New York. Waitlisting within 1 year of evaluation start varied from 0% to 100% across 2188 facilities; median within-facility proportion was 41.2% (26.0%–60%), lowest in the Southeast (31.9% [20%–43.8%]) and similar across other regions (50%). Facilities in the lowest tertile of evaluation start proportions (&lt; 39.13%) more often treated patients from high-poverty neighborhoods (36.8% vs. 29.2%) and were for-profit (82.4% vs. 73.5%) than the highest tertile (&gt; 58.33%). These characteristics varied by region. Facility-level clustering explained 12.2% (95% confidence interval [CI]: 10.5%–13.5%) of variation in evaluation and 8.2% (6.7%–9.2%) in waitlisting.</div></div><div><h3>Conclusion</h3><div>Substantial regional variation in pretransplant access across dialysis facilities reinforces the need for region-specific strategies to improve access.</div></div>","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"11 3","pages":"Article 103721"},"PeriodicalIF":5.7,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145980201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gaps in Dialysis Staff Knowledge of the Kidney Transplantation Process 透析人员在肾移植过程知识上的差距
IF 5.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-12-12 DOI: 10.1016/j.ekir.2025.103720
Catherine E. Kelty , Kelsey M. Drewry , Jade Buford , Mengyu Di , Megan Urbanski , Adam S. Wilk , Stephen O. Pastan , Amy Waterman , Rachel E. Patzer

Introduction

For patients receiving dialysis, education from dialysis staff is vital to make informed treatment decisions. Effective education practices are predicated on dialysis staff being well-informed about the kidney transplant process. We assessed dialysis staff knowledge of the transplant process and described staff and facility characteristics associated with knowledge.

Methods

A 17-item adaptation of the Knowledge Assessment of Renal Transplantation (KART) instrument was used to assess dialysis staff knowledge of the kidney transplantation process. Surveys were emailed to 2000 dialysis centers across 4 US regions (August 2021–August 2022). Associations between staff and facility characteristics and correct response scores were assessed using analysis of variance and by ordinal regression for score quartiles.

Results

Of the 630 responses assessed (among 33.5% response rate), respondents were mostly female (91.4%), social workers (81.1%), and worked at chain-owned facilities (86.2%). The average correct response score was 11.8 (69%). Correct responses for individual items ranged from 9.4% to 95.9%. In the adjusted regressions, the odds of scoring highly was reduced for non–social workers (vs. social workers; adjusted odds ratio [aOR]: 0.39; 95% confidence interval [CI]: 0.25–0.63), time working in role (vs. 8–10 years; < 1 year aOR: 0.11 [95% CI: 0.04–0.25], 1–3 years aOR: 0.21 [95% CI: 0.10–0.43], 4–7 years aOR: 0.38 [95% CI: 0.19–0.78], > 10 years aOR: 0.42 [95% CI: 0.21–0.85]), and region (vs. Southeast; New York aOR: 0.52 [95% CI: 0.29–0.94]).

Conclusion

The adapted-KART assessment revealed significant gaps and variation in dialysis staff knowledge of transplantation processes. Interventions to improve staff training and reduce gaps in staff knowledge are needed to ensure appropriate patient education regarding kidney transplantation for patients receiving dialysis.
对于接受透析的患者,透析人员的教育对于做出明智的治疗决定至关重要。有效的教育实践是建立在透析人员充分了解肾移植过程的基础上的。我们评估了透析人员对移植过程的知识,并描述了与知识相关的人员和设施特征。方法采用肾移植知识评估量表(KART)的17个项目对透析人员进行肾移植知识评估。调查通过电子邮件发送到美国4个地区的2000个透析中心(2021年8月至2022年8月)。使用方差分析和分数四分位数的有序回归来评估工作人员和设施特征与正确反应分数之间的关联。结果630份问卷(33.5%的回复率)中,女性居多(91.4%),社会工作者居多(81.1%),连锁机构工作人员居多(86.2%)。平均正确回答得分为11.8分(69%)。对个别问题的正确回答从9.4%到95.9%不等。在调整回归中,非社会工作者(相对于社会工作者,调整优势比[aOR]: 0.39; 95%可信区间[CI]: 0.25-0.63)、工作时间(相对于8-10年;1年or: 0.11 [95% CI: 0.04-0.25]、1 - 3年or: 0.21 [95% CI: 0.10-0.43]、4-7年or: 0.38 [95% CI: 0.19-0.78]、10年or: 0.42 [95% CI: 0.21 - 0.85])和地区(相对于东南、纽约aOR: 0.52 [95% CI: 0.29-0.94])获得高评分的几率降低。结论适应性kart评估显示透析人员对移植过程的知识存在显著差距和差异。需要采取干预措施,改善工作人员培训,缩小工作人员知识差距,以确保接受透析的患者接受适当的肾移植患者教育。
{"title":"Gaps in Dialysis Staff Knowledge of the Kidney Transplantation Process","authors":"Catherine E. Kelty ,&nbsp;Kelsey M. Drewry ,&nbsp;Jade Buford ,&nbsp;Mengyu Di ,&nbsp;Megan Urbanski ,&nbsp;Adam S. Wilk ,&nbsp;Stephen O. Pastan ,&nbsp;Amy Waterman ,&nbsp;Rachel E. Patzer","doi":"10.1016/j.ekir.2025.103720","DOIUrl":"10.1016/j.ekir.2025.103720","url":null,"abstract":"<div><h3>Introduction</h3><div>For patients receiving dialysis, education from dialysis staff is vital to make informed treatment decisions. Effective education practices are predicated on dialysis staff being well-informed about the kidney transplant process. We assessed dialysis staff knowledge of the transplant process and described staff and facility characteristics associated with knowledge.</div></div><div><h3>Methods</h3><div>A 17-item adaptation of the Knowledge Assessment of Renal Transplantation (KART) instrument was used to assess dialysis staff knowledge of the kidney transplantation process. Surveys were emailed to 2000 dialysis centers across 4 US regions (August 2021–August 2022). Associations between staff and facility characteristics and correct response scores were assessed using analysis of variance and by ordinal regression for score quartiles.</div></div><div><h3>Results</h3><div>Of the 630 responses assessed (among 33.5% response rate), respondents were mostly female (91.4%), social workers (81.1%), and worked at chain-owned facilities (86.2%). The average correct response score was 11.8 (69%). Correct responses for individual items ranged from 9.4% to 95.9%. In the adjusted regressions, the odds of scoring highly was reduced for non–social workers (vs. social workers; adjusted odds ratio [aOR]: 0.39; 95% confidence interval [CI]: 0.25–0.63), time working in role (vs. 8–10 years; &lt; 1 year aOR: 0.11 [95% CI: 0.04–0.25], 1–3 years aOR: 0.21 [95% CI: 0.10–0.43], 4–7 years aOR: 0.38 [95% CI: 0.19–0.78], &gt; 10 years aOR: 0.42 [95% CI: 0.21–0.85]), and region (vs. Southeast; New York aOR: 0.52 [95% CI: 0.29–0.94]).</div></div><div><h3>Conclusion</h3><div>The adapted-KART assessment revealed significant gaps and variation in dialysis staff knowledge of transplantation processes. Interventions to improve staff training and reduce gaps in staff knowledge are needed to ensure appropriate patient education regarding kidney transplantation for patients receiving dialysis.</div></div>","PeriodicalId":17761,"journal":{"name":"Kidney International Reports","volume":"11 3","pages":"Article 103720"},"PeriodicalIF":5.7,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145980939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Kidney International Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1